Teva Pharmaceuticals on Twitter: "@Kgen68992973 To report an adverse event with a Teva product, please call our Medical Info Center 1-888-838 2872 or email drug.safety@tevapharm.com." / Twitter
Teva's Perfect Storm Sends Tel-Aviv Stock Exchange Down | Ctech
Mark Sabag on LinkedIn: ESG Progress Report | Our Impact | Teva Pharmaceuticals
Teva Showcases Global Impact in 2019 Environmental, Social and Governance Progress Report | Business Wire
Teva Reports Fourth Quarter and Full Year 2020 Financial Results | Business Wire
Teva Reports Fourth Quarter and Full Year 2022 Financial Results | Business Wire
CSRWire - Teva Highlights Key Milestones Achieved in the 2017 Social Impact Report
Teva Reports Fourth Quarter and Full Year 2022 Financial Results | Business Wire
Teva's Environmental, Social and Governance (ESG) Progress in 2022 - YouTube
Teva Pharmaceuticals Stock Jumps After Reporting Earnings. What You Need to Know. | Barron's
Teva reports heavy losses, sees minimal 2023 growth - Globes
Teva Reports Third Quarter 2022 Financial Results
Teva Reports First Quarter 2023 Financial Results and Reaffirms 2023 Non-GAAP Outlook
Teva Reports Fourth Quarter and Full Year 2019 Financial Results | Business Wire
The Latest ESG Report Outlines Our Incredible Environmental and Social Efforts in 2020 | Teva api
Teva Factory Shutdown in Irvine Affects 25 Drugs: Report - Orange County Business Journal
Teva Generic Medicines Saved the United States $28.8 Billion in 2020, and a Total of $43.1 Billion Across Major Markets, According to Independent Analysis | Business Wire
Teva: A Complete Overview (NYSE:TEVA) | Seeking Alpha
Teva Reports Second Quarter 2020 Financial Results | Business Wire
Teva (TEVA) to Report Q4 Earnings: What's in the Cards?